Gilead Sciences, Inc Patent Portfolio Statistics

Gilead Sciences, Inc.

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Gilead Sciences, Inc. look like?

Assignee Art Units
Total Applications: 1,532 1,196,736
Granted Patents: 872 533,916
Grant Index 66.97% 63.42%
Abandoned/Rejected Applications: 430 (33.03%) 307,946 (36.58%)
In-Process Applications: 224 354,874
Average Grant Time: 2.42 Years 2.82 Years
Average Office Actions: 1.36 1.75

Which Technology Area Gilead Sciences, Inc. is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
1624 Organic Chemistry 196
1625 Organic Chemistry 138
1626 Organic Chemistry 128
1623 Organic Chemistry 110
1628 Organic Chemistry 103

How many patents are Gilead Sciences, Inc. filing every year?

Year Total Applications Predicted
2022 0* 313
2021 24* 384
2020 77 314
2019 68 68
2018 87
2017 102
2016 90
2015 95
2014 101
2013 85

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Gilead Sciences, Inc. in USPTO?

Publication number: None
Application number: 17/627,000


Publication date:
Applicant: Gilead Sciences, Inc.
Inventors: J John Leonard

Publication number: US20220177449A1
Application number: 17/530,300

The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition in a human.

Publication date: 2022-06-09
Applicant: Gilead Sciences, Inc.
Inventors: G James Taylor

How are Gilead Sciences, Inc.’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17/627,000 Long-Acting Formulations Of Tenofovir Alafenamide Application Undergoing Preexam Processing 1629
17/530,300 Glp-1R Modulating Compounds OPAP Central, Docket